Watson Pharmaceuticals Inc. and Akorn Inc. have shipped vancomycin hydrochloride capsules, an antibiotic used to treat infections of the intestines that cause colitis.


Watson Pharmaceuticals, Akorn, vancomycin hydrochloride capsules, Vancocin, generic Vancocin, ViroPharma, generic versions, antibiotic, infections of the intestines, cause colitis, Clostridium difficile-associated diarrhea, CDAD, enterocolitis
































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Watson, Akorn release generic Vancocin

April 10th, 2012

NEW YORK – Watson Pharmaceuticals Inc. and Akorn Inc. have shipped vancomycin hydrochloride capsules, an antibiotic used to treat infections of the intestines that cause colitis.

The companies said Tuesday that their products, offered in strengths of 125 mg and 250 mg, are generic versions of ViroPharma Inc.'s Vancocin.

According to Watson and Acorn, Vancocin is indicated for the treatment of Clostridium difficile-associated diarrhea (CDAD) and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.

Vancocin capsules had U.S. sales of $332 million for the 12 months ended Feb. 29, according to IMS Health figures cited by Watson.

Advertisement